196 related articles for article (PubMed ID: 30740936)
1. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis.
Rezk T; Gilbertson JA; Mangione PP; Rowczenio D; Rendell NB; Canetti D; Lachmann HJ; Wechalekar AD; Bass P; Hawkins PN; Bellotti V; Taylor GW; Gillmore JD
J Pathol Clin Res; 2019 Jul; 5(3):145-153. PubMed ID: 30740936
[TBL] [Abstract][Full Text] [Related]
2. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
[TBL] [Abstract][Full Text] [Related]
3. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
Tasaki M; Obayashi K; Ueda M; Ando Y
Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
[TBL] [Abstract][Full Text] [Related]
4. [Proteomics, a new tool for an accurate typing of amyloidosis].
Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
[TBL] [Abstract][Full Text] [Related]
5. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
6. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
[TBL] [Abstract][Full Text] [Related]
7. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
8. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
[TBL] [Abstract][Full Text] [Related]
9. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue.
Barreca A; Bottasso E; Veneziano F; Giarin M; Nocifora A; Martinetti N; Attanasio A; Biancone L; Benevolo G; Roccatello D; Cassoni P; Papotti MG;
PLoS One; 2021; 16(8):e0256306. PubMed ID: 34428239
[TBL] [Abstract][Full Text] [Related]
11. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
Leung N; Nasr SH; Sethi S
Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites.
Holub D; Flodrova P; Pika T; Flodr P; Hajduch M; Dzubak P
Biomed Res Int; 2019; 2019():3689091. PubMed ID: 30834260
[TBL] [Abstract][Full Text] [Related]
13. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
14. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.
Vrana JA; Gamez JD; Madden BJ; Theis JD; Bergen HR; Dogan A
Blood; 2009 Dec; 114(24):4957-9. PubMed ID: 19797517
[TBL] [Abstract][Full Text] [Related]
15. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
16. Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition.
Li D; Liu D; Xu H; Yu XJ; Zhou FD; Zhao MH; Wang SX
BMC Nephrol; 2019 Dec; 20(1):476. PubMed ID: 31870425
[TBL] [Abstract][Full Text] [Related]
17. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
[TBL] [Abstract][Full Text] [Related]
18. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.
Rowczenio D; Dogan A; Theis JD; Vrana JA; Lachmann HJ; Wechalekar AD; Gilbertson JA; Hunt T; Gibbs SD; Sattianayagam PT; Pinney JH; Hawkins PN; Gillmore JD
Am J Pathol; 2011 Oct; 179(4):1978-87. PubMed ID: 21820994
[TBL] [Abstract][Full Text] [Related]
19. [New advances in the subtyping of systemic amyloidosis].
Sun WY; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis.
Picken MM
Clin Kidney J; 2015 Dec; 8(6):665-72. PubMed ID: 26613021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
